GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Optiscan Imaging Ltd (ASX:OIL) » Definitions » ROE % Adjusted to Book Value

Optiscan Imaging (ASX:OIL) ROE % Adjusted to Book Value : -16.94% (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Optiscan Imaging ROE % Adjusted to Book Value?

Optiscan Imaging's ROE % for the quarter that ended in Dec. 2023 was -71.14%. Optiscan Imaging's PB Ratio for the quarter that ended in Dec. 2023 was 4.20. Optiscan Imaging's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -16.94%.


Optiscan Imaging ROE % Adjusted to Book Value Historical Data

The historical data trend for Optiscan Imaging's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optiscan Imaging ROE % Adjusted to Book Value Chart

Optiscan Imaging Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.22 -6.68 -2.57 -4.67 -5.65

Optiscan Imaging Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.23 -5.59 -6.68 -6.18 -16.94

Competitive Comparison of Optiscan Imaging's ROE % Adjusted to Book Value

For the Scientific & Technical Instruments subindustry, Optiscan Imaging's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Optiscan Imaging's ROE % Adjusted to Book Value Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Optiscan Imaging's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Optiscan Imaging's ROE % Adjusted to Book Value falls into.



Optiscan Imaging ROE % Adjusted to Book Value Calculation

Optiscan Imaging's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-90.33% / 16.00
=-5.65%

Optiscan Imaging's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-71.14% / 4.20
=-16.94%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optiscan Imaging ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Optiscan Imaging's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Optiscan Imaging (ASX:OIL) Business Description

Industry
Traded in Other Exchanges
N/A
Address
16 Miles Street, Mulgrave, Melbourne, VIC, AUS, 3170
Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation.

Optiscan Imaging (ASX:OIL) Headlines

From GuruFocus

Boone Pickens Makes New Prediction for Oil Prices

By Holly LaFon Holly LaFon 02-04-2016

Wilbur Ross Discusses Donald Trump, New EPA Rules on Fox Business

By Holly LaFon Holly LaFon 08-05-2015

T. Boone Pickens Calls an Oil Bottom

By Ryan Vanzo R. Vanzo 01-21-2016

Wilbur Ross: Oil Won't Go Above $50 'For a Long Time'

By Holly LaFon Holly LaFon 06-21-2016

T. Boone Pickens on Rig Count's Relations to Oil Prices

By Holly LaFon Holly LaFon 02-21-2015

CM Energy Industry Update - March 2017

By Holly LaFon Holly LaFon 03-14-2017

How to Value an Oil & Gas Company: Part 3

By Stepan Lavrouk Stepan Lavrouk 01-16-2019

Energy Investor T. Boone Pickens' 3 New Oil Stock Picks

By Holly LaFon Holly LaFon 01-07-2015

Arnold Van Den Berg's CM Outlook for Oil - January 2016

By Holly LaFon Holly LaFon 01-11-2016